Sign In
Buy SLQT
$0.747
+0.0204 (+2.81%)
At Close: Jul 31, 2026
SLQT CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against SelectQuote, Inc.
07:34pm, Monday, 11'th Aug 2025
LOS ANGELES--(BUSINESS WIRE)--SLQT CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against SelectQuote, Inc.
Investor Alert: Robbins LLP Informs Investors of the SelectQuote, Inc. Class Action Lawsuit
07:00pm, Monday, 11'th Aug 2025
SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired SelectQuote, Inc. (NYSE: SLQT) s
SLQT CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of SelectQuote, Inc. Investors
05:24pm, Monday, 11'th Aug 2025
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, cap
SelectQuote to Release Fiscal Fourth Quarter and Full Year 2025 Earnings on August 21
07:30am, Thursday, 07'th Aug 2025
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platfo
NEW YORK, July 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc.
SelectQuote: Be Patient Until Growth Drivers Kick In
11:14am, Saturday, 12'th Jul 2025
SelectQuote is undervalued at current levels, offering a compelling buying opportunity despite recent volatility and a disappointing Q3. Key catalysts include higher Medicare Advantage reimbursement r
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc.
Rosen Law Firm Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation - SLQT
11:46am, Tuesday, 08'th Jul 2025
NEW YORK , July 8, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NY
NEW YORK, July 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc.
Rosen Law Firm Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation - SLQT
03:02pm, Thursday, 03'rd Jul 2025
NEW YORK , July 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc.
SelectQuote Mourns the Passing of Tom Grant, Vice Chairman of the Board of Directors
04:15pm, Wednesday, 02'nd Jul 2025
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE:SLQT) announced today that William Thomas (Tom) Grant II, Vice Chairman and former President of SelectQuote, passed away on July 1, 2025,
What Makes SelectQuote (SLQT) a New Buy Stock
01:01pm, Wednesday, 02'nd Jul 2025
SelectQuote (SLQT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SelectQuote: Poised For Asymmetric Re-Rating
05:02am, Monday, 30'th Jun 2025
Compressing real yields and a Fed pivot position SelectQuote for a duration-driven re-rating as the market's 74 percent discount to peers is untenable against highly visible multi-year cash flows. AI-
